Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pangaea Oncology
Barcelona, Catalonia, Spainpanoncology.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Pangaea Oncology focuses on precision oncology, offering services to improve cancer patient outcomes through personalized medicine, molecular diagnostics, and R&D in liquid biopsy and NGS. Their AI-driven tools enhance patient characterization.
- Therapeutic areas
- Oncology
- Modalities
- Liquid BiopsyNext-Generation Sequencing (NGS)In Vitro Models
- Industry
- Molecular Diagnostics
02
Partnerships
Cancer Research Technology, UK
Beyond the preview
Go deeper on Pangaea Oncology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pangaea Oncology.